ILJIN SNT to Oppose Aurinia Pharmaceuticals’ Revised Incentive Plan
SEOUL, South Korea, June 7, 2024 -- Dear Fellow Shareholders, ILJIN SNT Co., Ltd. ("ILJIN") is a long-standing investor of...
SEOUL, South Korea, June 7, 2024 -- Dear Fellow Shareholders, ILJIN SNT Co., Ltd. ("ILJIN") is a long-standing investor of...